The following is a listing of recent U.S. Food and Drug Administration updates and activities:

• Bone Matrix Product: FDA Safety Communication - Important Information for Human Cell, Tissue and Cellular and Tissue-based Product (HCT/P) Establishments Regarding Tuberculosis Outbreaks

• Novartis Issues Voluntary Nationwide Recall of One Lot of Sandimmune® Oral Solution (Cyclosporine Oral Solution, USP), 100 mg/mL Due to Crystallization

• FDA Issues Warning Letters to Firms Marketin…

Sign Up for Free Trial

---

• Back
• MCN Blog